|
|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
|
C16.2 |
Malignant neoplasm of body of stomach
|
C162 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 57.38%
|
25.72%
|
8.49%
|
3.03%
|
1.70%
|
1.30%
|
0.74%
|
0.45%
|
0.27%
|
0.22%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C16.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2,252
|
2,258
|
|
80053
|
COMPREHEN METABOLIC PANEL |
2,231
|
2,231
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,876
|
1,884
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,471
|
1,484
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
716
|
70,729
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
625
|
625
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
622
|
622
|
|
71260
|
CT THORAX DX C+ |
601
|
601
|
|
96413
|
CHEMO IV INFUSION 1 HR |
567
|
567
|
|
A9552
|
F18 FDG |
508
|
508
|
|
78815
|
PET IMAGE W/CT SKULL-THIGH |
492
|
492
|
|
83735
|
ASSAY OF MAGNESIUM |
479
|
483
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
433
|
719
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
416
|
18,873
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
399
|
5,905
|
|
J9190
|
FLUOROURACIL INJECTION |
394
|
2,624
|
|
84443
|
ASSAY THYROID STIM HORMONE |
370
|
370
|
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
368
|
665
|
|
77386
|
NTSTY MODUL RAD TX DLVR CPLX |
361
|
361
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
356
|
12,130
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C16.2 related to the following DRG Codes:
374-376
|
